These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37153620)

  • 1. The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles.
    Navarini L; Vomero M; Currado D; Berardicurti O; Biaggi A; Marino A; Bearzi P; Corberi E; Rigon A; Arcarese L; Leuti A; Fava M; Fogolari M; Mattei A; Ruscitti P; Di Cola I; Sambuco F; Travaglino F; Angeletti S; Ursini F; Mariani E; Cipriani P; Agrò FE; Iagnocco A; Antonelli Incalzi R; Maccarrone M; Giacomelli R
    Front Immunol; 2023; 14():1148268. PubMed ID: 37153620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole.
    Duan M; Shen M; Zhou Y; He Y; Guo Z; Ye C; Li J; Zhu L
    Clin Rheumatol; 2023 Jun; 42(6):1635-1643. PubMed ID: 36418508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated circulating pro-inflammatory low-density granulocytes in adult-onset Still's disease.
    Liu Y; Xia C; Chen J; Fan C; He J
    Rheumatology (Oxford); 2021 Jan; 60(1):297-303. PubMed ID: 32757000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.
    Meng J; Ma Y; Jia J; Wang M; Teng J; Shi H; Liu H; Su Y; Ye J; Sun Y; Cheng X; Chi H; Liu T; Zhu D; Zhou Z; Wan L; Wang Z; Wang F; Qiao X; Chen X; Zhang H; Tang Z; Yang C; Hu Q
    Front Immunol; 2020; 11():603389. PubMed ID: 33552062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.
    Chi H; Liu D; Sun Y; Hu Q; Liu H; Cheng X; Ye J; Shi H; Yin Y; Liu M; Wu X; Zhou Z; Teng J; Yang C; Su Y
    Arthritis Res Ther; 2018 Mar; 20(1):54. PubMed ID: 29566725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19.
    Chen PK; Lan JL; Huang PH; Hsu JL; Chang CK; Tien N; Lin HJ; Chen DY
    Front Immunol; 2021; 12():719544. PubMed ID: 34367188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still's disease.
    Hu Q; Shi H; Zeng T; Liu H; Su Y; Cheng X; Ye J; Yin Y; Liu M; Zheng H; Wu X; Chi H; Zhou Z; Jia J; Sun Y; Teng J; Yang C
    Arthritis Res Ther; 2019 Jan; 21(1):9. PubMed ID: 30616678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease.
    Nagai H; Kirino Y; Nakano H; Kunishita Y; Henmi R; Szymanski AM; Yoshimi R; Ombrello MJ; Nakajima H
    Rheumatology (Oxford); 2021 Aug; 60(8):3888-3895. PubMed ID: 33550379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-derived lipocalin-2 in adult-onset Still's disease: a novel biomarker of disease activity and liver damage.
    Jia J; Yang L; Cao Z; Wang M; Ma Y; Ma X; Liu Q; Teng J; Shi H; Liu H; Cheng X; Ye J; Su Y; Sun Y; Chi H; Liu T; Wang Z; Wan L; Yang C; Hu Q
    Rheumatology (Oxford); 2021 Jan; 60(1):304-315. PubMed ID: 32766690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma galectin-3 levels and their correlation with disease activity in adult-onset Still's disease.
    Chen PK; Lan JL; Li JP; Chang CK; Chang SH; Huang PH; Yeo KJ; Chen DY
    Clin Rheumatol; 2020 Jun; 39(6):1945-1952. PubMed ID: 31960208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations.
    Kim HA; Han JH; Kim WJ; Noh HJ; An JM; Yim H; Jung JY; Kim YS; Suh CH
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.
    Jia J; Wang M; Ma Y; Meng J; Zhu D; Chen X; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Liu T; Zhou Z; Wang F; Chen L; Yi D; Xiao Y; Yang C; Teng J; Hu Q
    BMC Med; 2023 Dec; 21(1):507. PubMed ID: 38124139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.
    Ruscitti P; Berardicurti O; Di Cola I; Di Muzio C; Di Nino E; Giacomelli R; Cipriani P
    Clin Exp Immunol; 2022 May; 208(1):95-102. PubMed ID: 35467709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease.
    Ruscitti P; Cipriani P; Ciccia F; Di Benedetto P; Liakouli V; Berardicurti O; Carubbi F; Guggino G; Di Bartolomeo S; Triolo G; Giacomelli R
    Clin Exp Immunol; 2016 Oct; 186(1):30-8. PubMed ID: 27317930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
    Chen DY; Lan JL; Lin FJ; Hsieh TY
    Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The landscape of innate and adaptive immune cell subsets in patients with adult-onset Still's disease.
    Chi H; Hong X; Dai N; Chen L; Zhang H; Liu H; Cheng X; Ye J; Shi H; Hu Q; Meng J; Zhou Z; Jia J; Liu T; Wang F; Wang M; Ma Y; Chen X; You Y; Zhu D; Tang Z; Yang C; Teng J; Su Y; Sun Y
    Rheumatology (Oxford); 2024 Jul; 63(7):1987-1997. PubMed ID: 37756690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease.
    Ruscitti P; Ursini F; Berardicurti O; Masedu F; Bozzalla Cassione E; Naldi S; Di Cola I; Di Muzio C; De Stefano L; Di Nino E; Navarini L; Vomero M; Bugatti S; Valenti M; Mariani E; Iagnocco A; Montecucco C; Giacomelli R; Cipriani P
    Rheumatology (Oxford); 2022 Dec; 62(1):321-329. PubMed ID: 35438139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum levels of free interleukin-18 in adult-onset Still's disease.
    Girard C; Rech J; Brown M; Allali D; Roux-Lombard P; Spertini F; Schiffrin EJ; Schett G; Manger B; Bas S; Del Val G; Gabay C
    Rheumatology (Oxford); 2016 Dec; 55(12):2237-2247. PubMed ID: 27616144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
    Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
    Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.